Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Healthtrust
Moodys
Fuji
McKesson
Citi
Teva
Cipla
Merck

Generated: May 26, 2018

DrugPatentWatch Database Preview

MEZLIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Mezlin, and what generic alternatives are available?

Mezlin is a drug marketed by Bayer Pharms and is included in four NDAs.

The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. Additional details are available on the mezlocillin sodium monohydrate profile page.
Summary for MEZLIN
Drug patent expirations by year for MEZLIN
Medical Subject Heading (MeSH) Categories for MEZLIN
Synonyms for MEZLIN
(2S,5R,6R)-3,3-Dimethyl-6-((R)-2-(3-(methylsulfonyl)-2-oxo-1-imidazolidinecarboxamido)-2-phenylacetamido)-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-((R)-2-(3-(methylsulfonyl)-2-oxoimidazolidine-1-carboxamido)-2-phenylacetamido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxidanylidene-imidazolidin-1-yl)carbonylamino]-2-phenyl-ethanoyl]amino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxo-imidazolidine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[[(3-methylsulfonyl-2-oxo-1-imidazolidinyl)-oxomethyl]amino]-1-oxo-2-phenylethyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(2R)-2-(3-methanesulfonyl-2-oxoimidazolidine-1-carbonylamino)-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(2R)-2-{[(3-methanesulfonyl-2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((((3-(methylsulfonyl)-2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))
481M653
51481-65-3
59798-30-0
6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid
6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid
A828617
AB0010527
AC1LCV44
AK116080
AKOS016010407
AM024765
AN-8314
API0004682
AS-11668
AX8001403
C-23146
C07221
C21H24N5NaO8S2
C21H25N5O8S2
CAS-51481-65-3
CHEBI:6919
CHEMBL1731
CTK8G1109
D00NJJ
D05021
DB00948
DR003206
DSSTox_CID_3316
DSSTox_GSID_23316
DSSTox_RID_76973
DTXSID1023316
EINECS 257-233-8
Epitope ID:120371
FT-0630647
H704
KB-291397
Mezlocilina
Mezlocilina [INN-Spanish]
MEZLOCILLIN
Mezlocillin (USAN/INN)
Mezlocillin [USAN:INN:BAN]
Mezlocillin acid
MEZLOCILLIN SODIUM
Mezlocillin sodium monohydrate
Mezlocilline
Mezlocilline [INN-French]
Mezlocillinum
Mezlocillinum [INN-Latin]
MolPort-006-129-469
Multocillin
NCGC00167470-01
OH2O403D1G
SC-12204
SCHEMBL34075
ST24048104
Tox21_112474
UNII-OH2O403D1G
VA11291
YPBATNHYBCGSSN-VWPFQQQWSA-N
ZINC3831120

US Patents and Regulatory Information for MEZLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 062333-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 062333-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 062333-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 062372-003 May 13, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Colorcon
Argus Health
Baxter
McKesson
Moodys
Federal Trade Commission
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.